Cargando…
Increased autocrine interleukin‐6 production is significantly associated with worse clinical outcome in patients with chronic lymphocytic leukemia
Chronic lymphocytic leukemia (CLL) remains incurable with current standard therapy. We have previously reported that an increased expression of interleukin‐6 (IL‐6) receptor CD126 leads to resistance of CLL cells to chemotherapy and worse prognosis for patients with CLL. In this study, we determine...
Autores principales: | Wang, Hua‐Qing, Jia, Li, Li, Yu‐Ting, Farren, Timothy, Agrawal, Samir G., Liu, Feng‐Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6590298/ https://www.ncbi.nlm.nih.gov/pubmed/30623437 http://dx.doi.org/10.1002/jcp.28086 |
Ejemplares similares
-
STAT3 and NF-κB cooperatively control in vitro spontaneous apoptosis and poor chemo-responsiveness in patients with chronic lymphocytic leukemia
por: Liu, Feng-Ting, et al.
Publicado: (2016) -
Highly Sensitive and Accurate Assessment of Minimal Residual Disease in Chronic Lymphocytic Leukemia Using the Novel CD160-ROR1 Assay
por: Farren, Timothy W., et al.
Publicado: (2020) -
Autocrine stimulation of interleukin 1 beta in acute myelogenous leukemia cells
Publicado: (1987) -
T-cell dysfunction by pseudohypoxia and autocrine purinergic signaling in chronic lymphocytic leukemia
por: Montironi, Chiara, et al.
Publicado: (2023) -
Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche
por: Colombo, Michela, et al.
Publicado: (2016)